Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05941507 |
| Title | Phase 1/2 Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | LegoChem Biosciences, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars Sinai Medical Center | RECRUITING | Los Angeles | California | 90048 | United States | Details |
| Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02115 | United States | Details |
| University of Michigan | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| Mary Crowley Cancer Research | RECRUITING | Dallas | Texas | 75230 | United States | Details |
| MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Princess Margaret Cancer Centre | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |